Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation. (2023)
Attributed to:
Aldosterone-induced endothelial glycocalyx dysfunction, a potential therapeutic target in proteinuria?
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.medj.2023.09.002
PubMed Identifier: 37863058
Publication URI: http://europepmc.org/abstract/MED/37863058
Type: Journal Article/Review
Volume: 4
Parent Publication: Med (New York, N.Y.)
Issue: 11
ISSN: 2666-6340